Relative and Absolute Contraindications to Thrombolysis

Thrombolysis is a treatment option for patients with ongoing cardiac ischemia and presentation within 12 hours of onset of pain. However, there are both relative and absolute contraindications to this treatment.

Absolute contraindications include internal or heavy PV bleeding, acute pancreatitis or severe liver disease, esophageal varices, active lung disease with cavitation, recent trauma or surgery within the past 2 weeks, severe hypertension (>200/120 mmHg), suspected aortic dissection, recent hemorrhagic stroke, cerebral neoplasm, and previous allergic reaction.

Relative contraindications include prolonged CPR, history of CVA, bleeding diathesis, anticoagulation, blood pressure of 180/100 mmHg, peptic ulcer, and pregnancy or recent delivery.

It is important to consider these contraindications before administering thrombolysis as they can increase the risk of complications. Primary percutaneous coronary intervention is the preferred treatment option, but if not available, thrombolysis can be a viable alternative. The benefit of thrombolysis decreases over time, and a target time of <30 minutes from admission for commencement of thrombolysis is typically recommended.

Endocardial Cushion Defects

Endocardial cushion defects, also referred to as atrioventricular (AV) canal or septal defects, are a group of abnormalities that affect the atrial septum, ventricular septum, and one or both of the AV valves. These defects occur during fetal development when the endocardial cushions, which are responsible for separating the heart chambers and forming the valves, fail to develop properly. As a result, there may be holes or gaps in the septum, or the AV valves may not close properly, leading to a mix of oxygenated and deoxygenated blood in the heart. This can cause a range of symptoms, including shortness of breath, fatigue, poor growth, and heart failure. Treatment for endocardial cushion defects typically involves surgery to repair the defects and improve heart function.

Medications for Heart Failure: Uses and Contraindications

Diltiazem is a calcium channel blocker that can treat angina and hypertension, but it should be stopped in patients with chronic heart disease and heart failure due to its negative inotropic effects.

Spironolactone can alleviate leg swelling and is one of the three drugs that have been shown to reduce mortality in heart failure, along with ACE inhibitors and β-blockers.

Allopurinol is safe to use in heart failure patients as it is used for the prevention of gout and has no detrimental effect on the heart.

Paracetamol does not affect the heart and is safe to use in heart failure patients.

Lisinopril is an ACE inhibitor used to treat hypertension and angina, and stopping it can worsen heart failure. It is also one of the three drugs that have been shown to reduce mortality in heart failure. The mechanism by which ACE inhibitors reduce mortality is not fully understood.

Pericarditis as a Post-Viral Complication: Symptoms and Differential Diagnosis

Pericarditis, inflammation of the pericardium, can occur as a post-viral complication. Patients typically experience diffuse chest pain that improves when leaning forward, and a friction rub may be heard on cardiac auscultation. Diffuse ST segment elevations on ECG can be mistaken for myocardial infarction. In this case, the patient reported recent viral symptoms and then developed acute pericardial symptoms.

While systemic lupus erythematosus (SLE) can cause pericarditis, other symptoms such as rash, myalgia, or joint pain would be expected, along with a positive anti-nuclear antibodies test. Uraemia can also cause pericarditis, but elevated blood urea nitrogen would be present, and this patient has no history of kidney disease. Dressler syndrome, or post-myocardial infarction pericarditis, can cause diffuse ST elevations, but does not represent transmural infarction. Chest radiation can also cause pericarditis, but this patient has no history of radiation exposure.

Fallot’s Tetralogy

Fallot’s tetralogy is a congenital heart defect that consists of four features: ventricular septal defect, pulmonary stenosis, right ventricular hypertrophy, and an over-riding aorta. To diagnose this condition, doctors look for specific indicators. A step-down in oxygen saturation between the left atrium and left ventricle indicates a right to left shunt at the level of the ventricles, which is a sign of ventricular septal defect. Pulmonary stenosis is indicated by a significant gradient of 89 mmHg across the pulmonary valve, which is calculated by subtracting the right ventricular systolic pressure from the pulmonary artery systolic pressure. Right ventricular hypertrophy is diagnosed by high right ventricular pressures and a right to left shunt, as indicated by the oxygen saturations. Finally, an over-riding aorta is identified by a further step-down in oxygen saturation between the left ventricle and aorta. While this could also occur in cases of patent ductus arteriosus with right to left shunting, the presence of the other features of Fallot’s tetralogy makes an over-riding aorta the most likely cause of reduced oxygen saturation due to admixture of deoxygenated blood from the right ventricle entering the left heart circulation.

Virchow’s Triad and Its Three Categories of Thrombosis Factors

Virchow’s triad is a concept that explains the three main categories of factors that contribute to thrombosis. These categories include stasis, injuries or trauma to the endothelium, and blood hypercoagulability. Stasis refers to abnormal blood flow, which can be caused by various factors such as turbulence, varicose veins, and stasis. Injuries or trauma to the endothelium can be caused by hypertension or shear stress, which can damage veins or arteries. Blood hypercoagulability is associated with several conditions such as hyperviscosity, deficiency of antithrombin III, nephrotic syndrome, disseminated malignancy, late pregnancy, and smoking.

It is important to note that current thrombosis or past history of thrombosis and malignancy are not included in the triad. Malignancy is a specific procoagulant state, so it is covered under hypercoagulability. Virchow’s triad and its three categories of thrombosis factors can help healthcare professionals identify and manage patients who are at risk of developing thrombosis. By addressing these factors, healthcare professionals can help prevent thrombosis and its associated complications.

Diagnosis of Aortic Stenosis

There is a significant difference in pressure (81 mmHg) between the left ventricle and the aortic valve, indicating a critical case of aortic stenosis. Although hypertrophic obstructive cardiomyopathy (HOCM) can also cause similar pressure differences, the patient’s age and clinical information suggest that aortic stenosis is more likely.

To determine the severity of aortic stenosis, the valve area and mean gradient are measured. A valve area greater than 1.5 cm2 and a mean gradient less than 25 mmHg indicate mild aortic stenosis. A valve area between 1.0-1.5 cm2 and a mean gradient between 25-50 mmHg indicate moderate aortic stenosis. A valve area less than 1.0 cm2 and a mean gradient greater than 50 mmHg indicate severe aortic stenosis. A valve area less than 0.7 cm2 and a mean gradient greater than 80 mmHg indicate critical aortic stenosis.

Understanding the Different Types of Left Ventricular Dysfunction in Heart Failure

Left ventricular (LV) dysfunction can result in heart failure, which is a clinical diagnosis that can be caused by systolic or diastolic dysfunction, or both. Diastolic dysfunction is characterized by impaired LV relaxation, resulting in increased LV end-diastolic pressure but normal LV end-systolic volume. This type of dysfunction can be caused by factors such as LV hypertrophy from poorly controlled hypertension. On the other hand, impaired LV contraction results in systolic dysfunction, which is characterized by LV dilation, increased LV end-systolic and end-diastolic volumes, and increased LV end-diastolic pressure. It is important to differentiate between these types of LV dysfunction in order to properly diagnose and manage heart failure.

Treatment options for acute atrial fibrillation

Atrial fibrillation (AF) is a common arrhythmia that can lead to serious complications such as stroke and heart failure. When a patient presents with acute AF, it is important to determine the underlying cause and choose the appropriate treatment. Here are some treatment options for acute AF:

Treatment options for acute atrial fibrillation

Initial investigation

The patient should be investigated for any reversible causes of AF such as hyperthyroidism and alcohol. Blood tests and a chest X-ray should be performed to rule out any underlying conditions.

Medical cardioversion

If no reversible causes are found, medical cardioversion is the most appropriate treatment for haemodynamically stable patients who have presented within 48 hours of the onset of AF.

Anticoagulation therapy

If the patient remains in persistent AF for more than 48 hours, their CHA2DS2 VASc score should be calculated to determine the risk of emboli. If the score is high, anticoagulation therapy should be started.

Trial of b-blocker

Sotalol is often used in paroxysmal AF as a ‘pill in the pocket’ regimen. However, in acute first-time presentations without significant cardiac risk factors, cardioversion should be attempted first.

Intravenous adenosine

This treatment may transiently block the atrioventricular (AV) node and is commonly used in atrial flutter. However, it is not recommended for use in acute AF presentation in an otherwise well patient.

In conclusion, the appropriate treatment for acute AF depends on the underlying cause and the patient’s risk factors. It is important to choose the right treatment to prevent serious complications.

Coarctation of the Aorta and its Interventions

Coarctation of the aorta is a condition where the aorta narrows, usually distal to the left subclavian artery. This can cause an asymptomatic difference in upper and lower body blood pressures and can lead to left ventricular hypertrophy. The severity of the restriction varies, with severe cases presenting early with cardiac failure, while less severe cases can go undiagnosed into later childhood.

Interventions for coarctation of the aorta include stenting, excision and graft placement, and using the left subclavian artery to bypass the coarctation. An atrial septal defect and hypertrophic occlusive cardiomyopathy would not cause a blood pressure difference between the upper and lower body. Stress headaches and a flow murmur are not appropriate diagnoses for a child with hypertension, which should be thoroughly investigated for an underlying cause.

In contrast, transposition of the great arteries is a major cyanotic cardiac abnormality that presents in infancy. It is important to diagnose and treat coarctation of the aorta to prevent complications such as left ventricular hypertrophy and cardiac failure.